Antares Pharma, Inc. (ATRS)

[gi197845]

Thank you Hyperopia. Yes, it was a serious question and you explained it perfectly.

At this time, TLando is not competition, but if in the future it gets FDA approval, it could take a bit of market share from ATRS.

However, there is more than enough room for 2 or 3 T booster products in the market, especially if they have different delivery systems, etc.

I am not trying to scare anyone out of ATRS.

As a matter of fact, for me personally I think it's wise to be invested in ATRS and LPCN.